---
url: https://www.servicesaustralia.gov.au/crohns-disease-paediatric-patient
title: Crohn's disease - paediatric patient - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:40:21.853Z
source: servicesaustralia.gov.au
---
# Crohn's disease - paediatric patient

The PBS subsidises biological medicines for paediatric patients with severe or moderate to severe refractory Crohn's disease.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Treatment specifics](#a3)
-   [Authority applications](#a4)
-   [More information](#a5)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with adalimumab under the _National Health Act 1953_, section 85 for paediatric patients with severe refractory Crohn’s disease.

The PBS subsidises treatment with infliximab under the _National Health Act 1953_, section 100 for paediatric patients with moderate to severe refractory Crohn’s disease.

Where the term **biological** **medicine** appears, it refers to adalimumab and infliximab.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing biological medicines.

## Section 100 arrangements

### Infliximab

This item is only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending either:

-   an approved private hospital
-   a public hospital.

This item isn’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Treatment specifics

To be eligible for PBS-subsidised treatment with biological medicines for severe or moderate to severe refractory Crohn’s disease, patients must be treated by one of the following specialists:

-   gastroenterologist (code 87)
-   consultant physician (internal medicine specialising in gastroenterology) (code 81)
-   consultant physician (general medicine specialising in gastroenterology) (code 82)
-   paediatrician
-   specialist paediatric gastroenterologist.

## Authority applications

### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications for initial authority approval to prescribe PBS-subsidised biological medicines to treat severe or moderate to severe refractory Crohn’s disease can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [Crohn’s disease paediatric - initial authority application form](/pb085?context=20)
-   relevant attachments.

### Applying for change or recommencement of treatment

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

Applications to change or recommence authority approval to prescribe PBS-subsidised biological medicines to treat severe or moderate to severe refractory Crohn’s disease can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [Crohn’s disease paediatric - change or recommencement authority application form](/pb239?context=20)
-   relevant attachments.

### Applying for continuing treatment

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

Applications for continuing authority approval to prescribe PBS-subsidised biological medicines to treat severe or moderate to severe refractory Crohn’s disease can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [Crohn’s disease paediatric - continuing authority application form](/pb161?context=20)
-   relevant attachments.

After we approve the first application for continuing treatment, subsequent continuing applications for PBS-subsidised adalimumab are Authority Required (Streamlined). You don’t need authority approval from us for the listed quantity and repeats.

After we approve the first application for continuing treatment, subsequent continuing applications for PBS-subsidised biosimilar brands of infliximab are Authority Required (Streamlined). You don’t need authority approval from us for the listed quantity and repeats.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
